Mercy BioAnalytics Funding & Investors
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell - known as extracellular... Read more
mercybio.comTotal Amount Raised: $68,277,696
Mercy BioAnalytics Funding Rounds
Series A
$41,000,000
Series A Investors
Hatteras Venture PartnersBroadway AngelsNovalis LifeSciencesLabCorpSozo VenturesiSelect FundBrukerAmerican Cancer SocietyUndisclosed
$27,277,694
Undisclosed Investors
The Perkins Fund
Funding info provided by Diffbot.